A detailed history of Verdence Capital Advisors LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Verdence Capital Advisors LLC holds 4,007 shares of BSX stock, worth $366,440. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,007
Previous 3,842 4.29%
Holding current value
$366,440
Previous $295,000 13.56%
% of portfolio
0.03%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$72.96 - $84.0 $12,038 - $13,860
165 Added 4.29%
4,007 $335,000
Q2 2024

Jul 25, 2024

BUY
$67.33 - $77.71 $5,049 - $5,828
75 Added 1.99%
3,842 $295,000
Q1 2024

Apr 25, 2024

SELL
$57.6 - $68.62 $5,702 - $6,793
-99 Reduced 2.56%
3,767 $258,000
Q4 2023

Jan 31, 2024

BUY
$48.64 - $57.81 $188,042 - $223,493
3,866 New
3,866 $223,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $131B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Verdence Capital Advisors LLC Portfolio

Follow Verdence Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verdence Capital Advisors LLC with notifications on news.